Home > Healthcare > Pharmaceuticals > Finished Drug Form > Oxycodone Drugs Market
Oxycodone Drugs Market size was valued at USD 5.4 billion in 2023 and is expected to grow at a CAGR of 5.7% between 2024 and 2032, driven by factors such as the rise in incidence of chronic pain diseases such as cancer, neuropathic disease, musculoskeletal disorders, and various others.
Also, the increase in the number of surgical procedures increases the demand for oxycodone drugs to manage postoperative pain, thereby driving market growth. For instance, according to an article published in National Library of Medicine in September 2021, it has been reported that, globally, over 310 million major surgeries are performed each year with around 40 to 50 million in U.S. and 20 million in Europe. It is estimated that up to 15% have serious postoperative morbidity, and 5–15% readmitted within 30 days. Thus, the rapid increase in the number of surgical procedures conducted globally, have increase the demand for oxycodone drugs to treat post-operative pain, thereby propelling the market growth.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Oxycodone Drugs Market Size in 2023: | USD 5.4 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 5.7% |
2032 Value Projection: | USD 8.9 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 162 |
Tables, Charts & Figures: | 268 |
Segments covered: | Drug Type, Dosage Form, Indication, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Oxycodone medication is prescribed for alleviating intense pain that necessitates opioid therapy, particularly when alternative pain relief options have proven ineffective or are unsuitable. Classified as a narcotic analgesic, oxycodone operates on the central nervous system to mitigate pain. It is accessible in various forms such as capsules, tablets, and liquid, and is offered in diverse potencies.